| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $439.9M | +27.6% |
| R&D Expense | $48.9M | +49.1% |
| SG&A Expense | $143.3M | +24.9% |
| Operating Income | $126.3M | +36.4% |
| Pre-tax Income | $118.6M | +200.3% |
| Income Tax | $23.9M | +87.7% |
| Net Income | $94.8M | +172.3% |
| EPS (Basic) | $0.45 | +160.8% |
| EPS (Diluted) | $0.43 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $87.0M | +47.2% |
| Accounts Receivable | $67.9M | +37.0% |
| Current Assets | $166.0M | +41.9% |
| Total Assets | $531.0M | +10.8% |
| Current Liabilities | $84.9M | +25.2% |
| Long-term Debt | $395.9M | +36.2% |
| Total Liabilities | $484.0M | -20.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $141.5M | +49.0% |
| Capital Expenditures | $746K | -21.1% |
| Investing Cash Flow | -$8.6M | -61.2% |
| Financing Cash Flow | -$105.0M | -78.4% |
| Free Cash Flow | $140.8M | +49.7% |
| +158.1% |
| Stockholders' Equity |
| $47.0M |
| +135.7% |